Merck Announces First-Quarter 2027 Dividend
Key Highlights
- ➤Merck (MRK) declares $0.88-per-share first-quarter 2027 dividend
- ➤Dividend payment scheduled for January 8, 2027
- ➤Shareholders of record date set for December 15, 2026
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.88 per share of the company’s common stock for the first quarter of 2027. Payment will be made on January 8, 2027, to shareholders of record at the close of business on December 15, 2026.
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter) (link) , Facebook , Instagram , YouTube and LinkedIn .
Get started
Create a free account to read the full story.
